Skip to main content
. 2020 Mar 6;12(3):615. doi: 10.3390/cancers12030615
CDKs cyclin-dependent kinases
CDKIs cyclin-dependent kinase inhibitors
DMSO Dimethyl sulfoxide
EMT epithelial-mesenchymal transition
FBS Fetal Bovine Serum
HCC hepatocellular carcinoma
MAPK mitogen-activated protein kinase
mTOR mammalian target of rapamycin
PARP proteolytic cleavage of poly (ADP ribose) polymerase
PKB Protein kinase B
Rb retinoblastoma tumor suppressor